HNF4A and metabolic dysfunction-associated steatotic liver disease: Overexpression of HNF4α has an effect of protecting lipotoxicity in the lipotoxicity condition caused by PA treatment, but inhibition of HNF4α is more effective in the NAFLD condition, where bile acid toxicity and lipotoxicity co-exist.